Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Avanos Medical, Inc. (AVNS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
20.96-1.07 (-4.86%)
At close: 04:00PM EDT
20.96 -0.01 (-0.05%)
After hours: 04:10PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • G
    Genesis_Gekko
    Trying to find reason for big pop today. Any ideas?
  • N
    Nic
    Joe,
    The market isn't buying your organic 3-5% growth plan. You failed again on your M&A plan. Please sell to someone who can scale!!!
  • N
    Nic
    The only people making money on AVNS are the management who keep getting shares awarded while the shareholders are diluted once again. No Growth Joe used our cash to buy back shares just to issue more shares to management.
  • r
    robby_roadkill
    When will it pay a dividend?
  • G
    Genesis_Gekko
    Why have earnings gone down so much? This thing is a a deep bear market.
  • Z
    Zephyr
    the DOJ says
    Avanos Medical to Pay $22 Million to resolve Criminal Charges related to Fraud

    https://www.justice.gov/opa/pr/avanos-medical-inc-pay-22-million-resolve-criminal-charge-related-fraudulent-misbranding-its
    Neutral
  • N
    Nic
    Avanos is buying OrthogenRx, in large part, with debt. A few days later Avanos announces authorization to purchase up to $30M in stock with cash on hand. Isn't that the equivalent of borrowing money to buy back stock?
  • W
    WealthMastersClub1
    $BIIB conversation
    Congrats BIIB Longs! Next >>>> A unique approach to treating AD --- a small molecule, orally administered, anti-inflammatory, insulin-sensitizing agent with a novel mechanism of action is entering a pivotal phase 3 clinical trial for the treatment of mild to moderate Alzheimer’s disease. BioVie $BIVI to acquire Neurmedix assets. $SAVA $AVNS $AVXL
    https://finance.yahoo.com/news/biovie-announces-amended-terms-asset-121900612.html
  • J
    John
    Lost $30 in a few months. Disaster.
  • N
    Nic
    Maybe you can sell AVNS to one of your M&A targets who know how to grow?
  • N
    Nic
    The last 2 quarters Joe Woody teased that they expected to announce, this year, the purchase of one or more strategic partners. We should know soon......
  • N
    Nic
    I would have expected a bigger revenue number considering post Covid surgery recovery plus acquisitions. No growth Joe seems able to only grow debt.

    Now we're well below the share repurchase price that was done in conjunction with a debt laden acquisition. Well done?
  • N
    Nic
    2-4% YOY top line growth? If that is what we are to expect we're way overpriced!
  • N
    Nic
    Not so sure about the growth strategy of this one...Last investor conference they talked about mid single digit organic growth and m&a in the $7-35 million range. Not much for a $2B company.
  • Y
    Yahoo Finance Insights
    Avanos Medical is up 5.04% to 30.66
  • Y
    Yahoo Finance Insights
    AVNS is up 5.65% to 69.79
  • Y
    Yahoo Finance Insights
    HYH is up 5.04% to 50.69
Advertisement
Advertisement